NLRX1 can counteract innate immune response induced by an external stimulus favoring HBV infection by competitive inhibition of MAVS-RLRs signaling in HepG2-NTCP cells.
Qian JiaoWenxiong XuXiaoyan GuoHuiyuan LiuBaolin LiaoXiang ZhuChuming ChenFangji YangLina WuChan XieLiang PengPublished in: Science progress (2022)
NLRX1 can counteract innate immune response induced by an external stimuli favoring hepatitis B virus infection by competitive inhibition of MAVS-RLRs signaling in HepG2-NTCP cells. Inhibition of the MAVS-RLR-mediated signaling pathways leads to a decline in the expression levels of I-IFN and IL-6.